hormone related cancer

In a large cohort of men, pre‐diagnostic use of metformin and testosterone replacement therapy was associated with lower incidence of prostate and colorectal cancers, but not male breast cancer, according to research. “The greatest reduced risks of prostate and colorectal cancers were observed...